Predicting long-term response to strong opioids in patients with low back pain: findings from a randomized, controlled trial of transdermal fentanyl and morphine
2007

Predicting Long-Term Response to Strong Opioids in Low Back Pain Patients

Sample size: 680 publication Evidence: moderate

Author Information

Author(s): Eija Kalso, Karen H Simpson, Robert Slappendel, Joachim Dejonckheere, Ute Richarz

Primary Institution: Helsinki University Central Hospital

Hypothesis

Can we predict which patients with low back pain will respond well to strong opioids?

Conclusion

A one-month trial period is generally sufficient to determine if patients will benefit from strong opioid treatment.

Supporting Evidence

  • Over half the patients in both groups were treatment responders.
  • The difference in response to treatment could be detected at 3 weeks.
  • A lack of response after 1 month had a stronger negative predictive value than the presence of response.

Takeaway

Doctors want to know who will feel better with strong pain medicine, but it's hard to tell before they start. A month of trying the medicine usually shows if it helps.

Methodology

Secondary analysis of a 13-month randomized trial comparing transdermal fentanyl and sustained-release oral morphine.

Potential Biases

The study included only carefully selected patients with a long history of chronic low back pain.

Limitations

The study was not originally designed to test predictors, and many potentially important factors were not examined.

Participant Demographics

Median age 52 years, 61% women, median duration of back pain 87 months.

Statistical Information

P-Value

p = 0.0259

Confidence Interval

95% CI 1.77–5.68

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1741-7015-5-39

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication